Navigation Links
Research Confirms Better Oil from New DuPont High Oleic Soybean Trait

Bunge, DuPont Alliance on Track to Deliver First Biotech Product with

Direct Consumer Benefits

DES MOINES, Iowa, March 18 /PRNewswire-FirstCall/ -- New oil testing results confirm a new, improved soybean oil trait from DuPont (NYSE: DD) will deliver increased nutritional benefits with broader applications than other soybean oil products currently on the market. The high oleic soybean oil trait is the next generation of improved oil products developed by DuPont business Pioneer Hi-Bred as part of the Bunge DuPont Biotech Alliance.

"We are breaking ground on a new oil product that will bring more nutritional benefits to consumers and better performance to the food industry," said William S. Niebur, DuPont vice president, Crop Genetics Research and Development. "These positive research results bring us one step closer to delivering the first biotech product with direct consumer benefits."

New oil testing results from high oleic soybeans produced in 2007 confirm that the oil contains at least 80 percent oleic acid, significantly increasing the stability of the oil when used in frying and food processing. Like low linolenic soybean oil, high oleic soybean oil eliminates the need for hydrogenation, resulting in foods with negligible amounts of trans fats.

High oleic soybean oil also presents opportunities for transportation and industrial applications. The oil's high stability will allow companies to develop renewable, environmentally sustainable options to petroleum-based products.

"The high oleic soybean oil trait will deliver enhanced nutrition, sustainability and functionality," Niebur said. "We are very excited to bring a superior product to market that will help meet the growing demand for nutritionally improved oils and provide valuable contracting opportunities for farmers."

In addition to delivering at least 80 percent oleic acid, the high oleic soybean oil trait has consistently demonstrated a linolenic acid content of less than 3 percent, and over 20 percent less saturated fatty acids than commodity soybean oil.

The oil will be available to food companies for testing following the 2008 growing season. This will allow food industry customers to conduct independent high oleic soybean oil testing in advance of commercial quantities being available after the 2009 soybean harvest.

The high oleic soybean oil produced from Pioneer(R) brand soybean varieties will be marketed as TREUS(R) High Oleic Soybean Oil. The TREUS(TM) brand name represents the industry-leading family of soy products developed as part of the Bunge DuPont Biotech Alliance. The high oleic soybean oil trait is on track for 2009 commercial introduction in the United States, pending regulatory approvals.

The Bunge DuPont Biotech Alliance was formed in 2003 to continue research and commercialize value-added soybean output traits developed through Pioneer soybean research and marketed through Bunge North America.

Bunge North America, the North American operating arm of Bunge Limited (NYSE: BG), is a vertically integrated food and feed ingredient company, supplying raw and processed agricultural commodities and specialized food ingredients to a wide range of customers in the livestock, poultry, food processor, foodservice and bakery industries. With headquarters in St. Louis, Missouri, Bunge North America and its subsidiaries operate grain elevators, oilseed processing plants, edible oil refineries and packaging facilities, and corn dry mills in the U.S., Canada and Mexico.

Pioneer Hi-Bred, a DuPont business, is the world's leading source of customized solutions for farmers, livestock producers and grain and oilseed processors. With headquarters in Des Moines, Iowa, Pioneer provides access to advanced plant genetics in nearly 70 countries.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

The DuPont Oval Logo, DuPont(TM), The miracles of science(TM), and Pioneer(R), TREUS(R) and TREUS(TM) are registered trademarks or trademarks of DuPont or its affiliates.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
4. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
5. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
6. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
7. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
8. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
Post Your Comments:
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):